We also examined whether the BAT could discriminate between patients with severe peanut allergy and sensitized patients with no or mild symptoms in order to evaluate if a person is no longer severely allergic to peanut even when displaying persistent IgE-mediated peanut sensitivity, as assessed using conventional tests, including reactivities to allergen components. The gene discussed is IGHE; the disease is peanut allergic reaction.